These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 30801830)

  • 1. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
    Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
    Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
    Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
    Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency.
    Engelhardt KR; Gertz ME; Keles S; Schäffer AA; Sigmund EC; Glocker C; Saghafi S; Pourpak Z; Ceja R; Sassi A; Graham LE; Massaad MJ; Mellouli F; Ben-Mustapha I; Khemiri M; Kilic SS; Etzioni A; Freeman AF; Thiel J; Schulze I; Al-Herz W; Metin A; Sanal Ö; Tezcan I; Yeganeh M; Niehues T; Dueckers G; Weinspach S; Patiroglu T; Unal E; Dasouki M; Yilmaz M; Genel F; Aytekin C; Kutukculer N; Somer A; Kilic M; Reisli I; Camcioglu Y; Gennery AR; Cant AJ; Jones A; Gaspar BH; Arkwright PD; Pietrogrande MC; Baz Z; Al-Tamemi S; Lougaris V; Lefranc G; Megarbane A; Boutros J; Galal N; Bejaoui M; Barbouche MR; Geha RS; Chatila TA; Grimbacher B
    J Allergy Clin Immunol; 2015 Aug; 136(2):402-12. PubMed ID: 25724123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
    Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
    Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotyping and long-term follow up of patients with hyper IgE syndrome.
    Alyasin S; Esmaeilzadeh H; Ebrahimi N; Nabavizadeh SH; Kashef S; Esmaeilzadeh E; Babaei M; Amin R
    Allergol Immunopathol (Madr); 2019; 47(2):152-158. PubMed ID: 30279075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyper-IgE syndromes].
    He YY; Liu B; Xiao XP
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Profile of Hyper-IgE Syndrome in India.
    Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
    Front Immunol; 2021; 12():626593. PubMed ID: 33717144
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical, immunological and genetic features in Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES).
    Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Ou LS; Yao TC; Hsieh MY; Huang YC; Yu HR; Kuo HC; Yang KD; Jaing TH
    Immunobiology; 2011 Aug; 216(8):909-17. PubMed ID: 21324546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
    Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
    J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients.
    Alsum Z; Hawwari A; Alsmadi O; Al-Hissi S; Borrero E; Abu-Staiteh A; Khalak HG; Wakil S; Eldali AM; Arnaout R; Al-Ghonaium A; Al-Muhsen S; Al-Dhekri H; Al-Saud B; Al-Mousa H
    J Clin Immunol; 2013 Jan; 33(1):55-67. PubMed ID: 22968740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations of hyper IgE syndromes.
    Freeman AF; Holland SM
    Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis.
    Kasap N; Celik V; Isik S; Cennetoglu P; Kiykim A; Eltan SB; Nain E; Ogulur I; Baser D; Akkelle E; Celiksoy MH; Kocamis B; Cipe FE; Yucelten AD; Karakoc-Aydiner E; Ozen A; Baris S
    Clin Immunol; 2021 Feb; 223():108645. PubMed ID: 33301882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of CCR4+ activated T cells is associated with memory B cell reduction in DOCK8-deficient patients.
    Caracciolo S; Moratto D; Giacomelli M; Negri S; Lougaris V; Porta F; Pajno G; Salpietro A; Montin D; Dinwiddie DL; Kingsmore SF; Plebani A; Badolato R
    Clin Immunol; 2014; 152(1-2):164-70. PubMed ID: 24674883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review regarding the prevalence of malignancy in patients with the hyper-IgE syndrome.
    Mohammadi T; Azizi G; Rafiemanesh H; Farahani P; Nirouei M; Tavakol M
    Clin Exp Med; 2023 Dec; 23(8):4835-4859. PubMed ID: 37924455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
    Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
    J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation.
    Al Shekaili L; Sheikh F; Al Gazlan S; Al Dhekri H; Al Mousa H; Al Ghonaium A; Al Saud B; Al Mohsen S; Rehan Khaliq AM; Al Sumayli S; Al Zahrani M; Dababo A; AlKawi A; Hawwari A; Arnaout R
    Clin Immunol; 2017 May; 178():39-44. PubMed ID: 27890707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal recessive hyper-IgE syndrome caused by DOCK8 gene mutation with new clinical features: a case report.
    Yang J; Liu Y
    BMC Neurol; 2021 Jul; 21(1):288. PubMed ID: 34301197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyper-IgE Syndromes and the Lung.
    Freeman AF; Olivier KN
    Clin Chest Med; 2016 Sep; 37(3):557-67. PubMed ID: 27514600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation.
    Bittner TC; Pannicke U; Renner ED; Notheis G; Hoffmann F; Belohradsky BH; Wintergerst U; Hauser M; Klein B; Schwarz K; Schmid I; Albert MH
    Klin Padiatr; 2010 Nov; 222(6):351-5. PubMed ID: 21058221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the hyper-IgE syndromes.
    Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B
    Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.